These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1970933)
1. [Involvements of neuropeptides in pentylenetetrazol-induced convulsion in rats and effects of TRH and ceruletide on the convulsion]. Hashiguchi S; Masuda T; Fujimoto H; Kawai H; Saito S No To Shinkei; 1990 Jan; 42(1):73-8. PubMed ID: 1970933 [TBL] [Abstract][Full Text] [Related]
2. [Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex]. Masuda T; Fujimoto H; Kawai H; Saito S Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):362-74. PubMed ID: 2842204 [TBL] [Abstract][Full Text] [Related]
3. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980 [TBL] [Abstract][Full Text] [Related]
4. [Effect of amygdaloid kindling on thyrotropin-releasing hormone, somatostatin, cholecystokinin and substance P contents of the amygdala/piriform cortex and hippocampus of rats]. Kajita S; Yamashita K; Nakashima M; Otsuki S; Ogawa N; Sato M No To Shinkei; 1988 Jun; 40(6):525-30. PubMed ID: 2465012 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin-like immunoreactivity and somatostatin receptor binding in rat brain before and after pentylenetetrazol-induced convulsion. Pitkänen A; Sirviö J; Jolkkonen J; Riekkinen P Neuropeptides; 1986 Jan; 7(1):63-71. PubMed ID: 2869441 [TBL] [Abstract][Full Text] [Related]
6. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Quirion R; Welner S; Gauthier S; Bédard P Synapse; 1987; 1(6):559-66. PubMed ID: 2843996 [TBL] [Abstract][Full Text] [Related]
7. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment. Ahmed MM; Arif M; Chikuma T; Kato T Neurochem Int; 2005 Sep; 47(4):248-59. PubMed ID: 15985312 [TBL] [Abstract][Full Text] [Related]
8. Bowel resection and neurotensin treatment. Histochemical study of neurotensin-like and somatostatin-like immunoreactivities and receptors. Toledano A; Rodríguez-Arellano JJ; Gómez de Segura IA; De Miguel E; Martínez-Rodríguez R Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1145-58. PubMed ID: 8997519 [TBL] [Abstract][Full Text] [Related]
9. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor. Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272 [TBL] [Abstract][Full Text] [Related]
10. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13). Donato di Paola E; Cusack B; Yamada M; Richelson E J Pharmacol Exp Ther; 1993 Jan; 264(1):1-5. PubMed ID: 8380855 [TBL] [Abstract][Full Text] [Related]
11. Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin. Scarcériaux V; Souazé F; Bachelet CM; Forgez P; Bourdel E; Martinez J; Rostène W; Pélaprat D J Neuroendocrinol; 1996 Aug; 8(8):587-93. PubMed ID: 8866245 [TBL] [Abstract][Full Text] [Related]
12. Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. Stenfors C; Theodorsson E; Mathé AA J Neurosci Res; 1989 Nov; 24(3):445-50. PubMed ID: 2480456 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptides and electroconvulsive treatment. Mathé AA J ECT; 1999 Mar; 15(1):60-75. PubMed ID: 10189619 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological characterization of somatostatin receptors in rat brain. Sato H; Ota Z; Ogawa N Res Commun Chem Pathol Pharmacol; 1989 Nov; 66(2):203-18. PubMed ID: 2574901 [TBL] [Abstract][Full Text] [Related]
15. The effect of centrally administered neuropeptides on the development of stress-induced gastric ulcers in rats. Hernandez DE; Nemeroff CB; Orlando RC; Prange AJ J Neurosci Res; 1983; 9(2):145-57. PubMed ID: 6302295 [TBL] [Abstract][Full Text] [Related]
16. [Effect of intracerebroventricular neurotensin injection on blood pressure in rat]. Zhang XH; Yin GX; Ni H Sheng Li Xue Bao; 1999 Apr; 51(2):140-6. PubMed ID: 11499007 [TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574 [TBL] [Abstract][Full Text] [Related]
18. Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate. Levant B; Nemeroff CB J Pharmacol Exp Ther; 1990 Jul; 254(1):330-5. PubMed ID: 1973198 [TBL] [Abstract][Full Text] [Related]
19. Increase in dopamine metabolites in rat brain by neurotensin. Widerlöv E; Kilts CD; Mailman RB; Nemeroff CB; Mc Cown TJ; Prange AJ; Breese GR J Pharmacol Exp Ther; 1982 Oct; 223(1):1-6. PubMed ID: 6811728 [TBL] [Abstract][Full Text] [Related]
20. [Effect of intracerebral injections of somatostatin and neurotensin on motor functions in seizure]. Shandra OA; Hodlevskyĭ LS; Vastíanov RS; Panenko AV Fiziol Zh (1978); 1993; 39(5-6):76-82. PubMed ID: 7913897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]